These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11092516)

  • 1. Regulation of leptin release by troglitazone in human adipose tissue.
    Fain JN; Cowan GS; Buffington C; Andersen RN; Pouncey L; Bahouth SW
    Metabolism; 2000 Nov; 49(11):1485-90. PubMed ID: 11092516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of leptin release by insulin, glucocorticoids, G(i)-coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture.
    Kanu A; Fain JN; Bahouth SW; Cowan GS
    Metabolism; 2003 Jan; 52(1):60-6. PubMed ID: 12524663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of leptin release by arachidonic acid and prostaglandin E(2) in adipose tissue from obese humans.
    Fain JN; Leffler CW; Cowan GS; Buffington C; Pouncey L; Bahouth SW
    Metabolism; 2001 Aug; 50(8):921-8. PubMed ID: 11474480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone, and influence of gender.
    Williams LB; Fawcett RL; Waechter AS; Zhang P; Kogon BE; Jones R; Inman M; Huse J; Considine RV
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2678-84. PubMed ID: 10946865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
    Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue.
    Lee MJ; Wang Y; Ricci MR; Sullivan S; Russell CD; Fried SK
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E858-64. PubMed ID: 17122089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
    Skurk T; Birgel M; Lee YM; Hauner H
    Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes.
    Fain JN; Madan AK
    Metabolism; 2005 Feb; 54(2):220-6. PubMed ID: 15690317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
    Barthel A; Krüger KD; Roth RA; Joost HG
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity.
    Halleux CM; Servais I; Reul BA; Detry R; Brichard SM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):902-10. PubMed ID: 9506746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies.
    Lappas M; Yee K; Permezel M; Rice GE
    J Endocrinol; 2005 Sep; 186(3):457-65. PubMed ID: 16135665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
    He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
    Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
    Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
    J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of troglitazone on leptin production. Studies in vitro and in human subjects.
    Nolan JJ; Olefsky JM; Nyce MR; Considine RV; Caro JF
    Diabetes; 1996 Sep; 45(9):1276-8. PubMed ID: 8772734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
    Willi SM; Kennedy A; Wallace P; Ganaway E; Rogers NL; Garvey WT
    Diabetes; 2002 Oct; 51(10):2895-902. PubMed ID: 12351424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.
    Walker AB; Naderali EK; Chattington PD; Buckingham RE; Williams G
    Diabetes; 1998 May; 47(5):810-4. PubMed ID: 9588454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
    Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
    Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.